Neoplasia intraepitelial cervical en mujeres menores de 25 años

Chávez Valdivia, Martha María; Quiñones Ceballos, Alfredo B.
Finlay revista enf crón ; 2(1)2012. tab
Artículo en Español | CUMED | ID: cum-49696

Documentos relacionados

  1. Risk-Based Cervical Consensus Guidelines: Methods to Determine Management if Less Than 5 Years of Data Are Available.
  2. Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature.
  3. Emerging Treatment Options for Cervical Dysplasia and Early Cervical Cancer.
  4. Cervical dysplasias 1982-2010 in the Republic of Panama. Diagnosis, treatment, and evolution.
  5. The Natural History of Cervical Intraepithelial Neoplasia Grades 1, 2, and 3: A Systematic Review and Meta-analysis.
  6. Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial.
  7. Should the management of high grade cervical squamous intraepithelial lesion (HSIL) be different in HIV-positive women?
  8. Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review.
  9. Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP.
  10. Characterization and clinical management of abnormal cytology findings in pregnant women: a retrospective analysis.